vanillin, lactic acid, N,N-diethyl-3-methylbenzamide, 4-nitrobenzylbromide, 1-naphthol, R-carvone, toluene-2,5-diamine (sulfate), and limonene were obtained from Sigma Aldrich (Taufkirchen, Germany) . N'-bis(4-aminophenyl)-2,5-diamino-1,4-quinonediimine (Bandrowski's base) was purchased from ICN Biomedicals (Aurora, OH, USA). Sodium dodecyl sulfate and dimethyl sulfoxide were purchased from Carl Roth (Karlsruhe, Germany). 4-Amino-2-methylacetanilide, 4-amino-3-methylacetanilide, 2,5diacetaminotoluene and 2-methoxymethyl-p-phenylenediamine, N-[4-amino-3-(methoxymethyl)phenyl]acetamide, N,N'-(2-(methoxymethyl)-1,4-phenylene)diacetamide were kindly provided by Procter and Gamble (P&G, Darmstadt, Germany) . The chemicals tested in the blind study (diphenylcyclopropenone, p-phenylenediamine, formaldehyde, methyldibromo glutaronitrile, isoeugenol, 2-mercaptobenzothiazole, resorcinol (benzene-1,3-diol) , coumarin, linalool, p-aminobenzoic acid, benzalkonium chloride, glycerol, salicylic acid, hydrocortisone, and propylparaben) were provided by VITO (Mol, Belgium).
The COCAT
The optimized Standard Operating Procedure (SOP version 9.5, Supplementary file 1 ) of the COCAT was used. Briefly, HaCaT cells were cultured in DMEM supplemented with 10% FCS and 1% antibiotics solution (complete HaCaT culture medium). THP-1 cells were cultured in RPMI supplemented with 10% FCS, 25 mM HEPES, 4 mM L-glutamine, 50 µM β-mercaptoethanol, and 1% antibiotics solution (complete THP-1 culture medium). On day 1, HaCaT cells were harvested, counted, and seeded in 96-well plates as 2.5 × 10 4 cells in 200 µl complete HaCaT culture medium per well. Cells were cultivated for 48 h at which time they were 100% confluent. On day 3, THP-1 cells were harvested, counted, and added to the wells containing confluent HaCaT cells (8 × 10 4 THP-1 cells in a total volume of 180 µl exposure medium (complete THP-1 culture medium excluding β-mercaptoethanol) per well, incl. test chemicals). Test chemicals were freshly dissolved, diluted (serial 2-fold dilution, 7.8-4000 µM), and added to the cells. 20 µM 2,4-dinitrochlorobenzene (DNCB) and 144 µM sodium dodecyl sulfate (SDS) was used as positive and negative control, respectively. Solvents used for dilution were dimethyl sulfoxide (DMSO, final concentration of 0.2%) or cell culture medium. The maximal test concentration (up to 4000 µM) for each test chemical was determined based on its solubility.
After 24 h treatment, floating THP-1 cells were harvested, washed with phosphate buffered saline (PBS), subdivided into 2 subsamples for each well, and stained with FITC-and APC-labelled anti-CD86 (clone 2331 [FUN-1]) and anti-CD54 antibodies (clone HA58), respectively, or corresponding isotype controls (all mouse IgG1, obtained from BD Pharmingen, Heidelberg, Germany). Cell surface expression of CD86 and CD54 on viable THP-1 cells was analyzed by flow cytometry using a FACSVerse™ (BD, Heidelberg, Germany) followed by analysis with BD FACSuite™ (BD Biosciences, Heidelberg, Germany). Viability of THP-1 cells was determined by exclusion of propidium iodide (PI, 10 μg/ml). For each sample, the mean fluores-ii) keratinocyte activation as the second key event (OECD, 2018b), and iii) activation of dendritic cells as the third key event (OECD, 2018a) . In addition, OECD Guidance Documents 255 and 256 (OECD, 2017a,b) have been adopted, which describe the use of integrated approaches for testing and assessment (IATA) and of defined approaches (DA) to assess skin sensitization hazard or potency of chemicals. To date, however, no alternative test method has been adopted to sub-categorize skin sensitizers into subcategories 1A and 1B as defined by the UN GHS (UN, 2017) or for determining skin sensitization potency.
Trier University, in collaboration with the Swiss Federal Office of Public Health, has developed a coculture model composed of HaCaT keratinocytes and THP-1 dendritic cell-like cells, namely the HaCaT/THP-1 Cocultured Activation Test (COCAT), which was found promising to identify skin sensitizers (Hennen et al., 2011; Hennen and Blömeke, 2017a) . Furthermore, the in vitro COCAT method was also shown to be able to identify the potency of skin sensitizers (Hennen and Blömeke, 2017a) and rank structurally related hair dye molecules Blömeke, 2017b, 2018) . Further, coculture of THP-1 cells with reconstructed human epidermis (RHE) takes penetration of the compounds into consideration (Schellenberger et al., 2019; Hennen et al., 2019) .
The COCAT combines two cell types that are individually used in two OECD TGs that address key events 2 and 3 of the skin sensitization AOP (i.e., HaCaT as main component of the OECD TG 442D for the KeratinoSens™ assay, and THP-1 as main component of the h-CLAT assay of the OECD TG 442E). This coculture allows a cross-talk between the two cell types and has been found, from preliminary data, to have the potential to: − enhance the response of THP-1 cells to sensitizing agents, leading to higher sensitivity; − detect pro-haptens; − support the identification of skin sensitization potency as shown by correlation with Local Lymph Node Assay (LLNA) potency. As information on skin sensitization potency is key in risk assessment of consumer and occupational exposures, a study was conducted to obtain data on the capacity of the COCAT to predict both skin sensitization hazard and potency, using an optimized test protocol. In this study, blind testing of chemicals was conducted in order to evaluate the intra-laboratory (between-run) reproducibility of the COCAT method and to assess its predictive capacity. The results obtained in the blind study, assessed both independently and combined with earlier results from the optimization phase, are presented here.
Material and methods

Test chemicals
The test chemicals oxazolone, citral, 2,4-dinitrochlorobenzene, 3-aminophenol, cinnamic aldehyde, tetramethylthiuram disulfide, 2-methoxy-4-methylphenol, eugenol, geraniol, cinnamic alcohol, cence intensity (MFI) of the isotype control stained subsample was subtracted from the MFI of the corresponding anti-CD86 or anti-CD54 stained subsample. Then, ΔMFI reflecting the absolute difference between chemical-treated cells and solvent-treated cells was calculated by subtraction. A chemical is considered a sensitizer if in ≥ 2 out of 3 runs at least one marker reaches its threshold for positivity (ΔMFI ≥ 10.8 for CD86 or ΔMFI ≥ 300 for CD54) at cell viability > 50%. A negative result obtained with a chemical that cannot be tested up to 4000 μM due to solubility issues was considered "inconclusive".
For estimation of sensitizing potency, the lowest concentration reaching positivity for CD54 or CD86 in each individual run (total of three runs) was calculated by linear interpolation or log-linear extrapolation in the case that the ΔMFI value at the lowest tested concentration already exceeded the threshold for positivity. The mean of these values is designated as the effective concentration (ECΔ, Fig. 1 ).
Design of the blind study
Following protocol optimization, an intra-laboratory blind study was conducted to evaluate the reproducibility between the runs of an experiment and the preliminary predictive capacity of the COCAT. The primary goal of the study was to evaluate the ability of the COCAT to reliably support the discrimination of skin sensitizers from non-sensitizers, and furthermore to subcategorize skin sensitizers according to the UN GHS classification system. 15 chemicals for which reliable reference LLNA data were available were selected and tested in the blind study. For each test chemical, one experiment comprising three independent runs (conducted on different days) and triplicates within each run was conducted.
Testing was conducted in accordance with OECD GLP principles as much as possible, such as, but not limited to, use of SOP, compliant equipment and materials, adequate data recording, and record keeping.
Chemical selection
The chemical selection was conducted independently by Services & Consultations on Alternative Methods (SeCAM, Switzerland), the Chemicals, Consumer Protection Directorate, Federal Office of Public Health (Switzerland), and seh consulting + services (Germany), safeguarding that the test developer and study laboratory (Trier University) was blinded to the test chemicals' identities. Table 1 shows the list of the 15 chemicals, which were selected using the following criteria: − High quality reference LLNA and human data; − Balanced distribution between sensitizers and non-sensitizers; − Representation of various skin sensitization potencies; − Inclusion of both haptens and pro-haptens; − Wide range of chemistry, use/function and physico-chemical properties;
Fig. 1: Schematic view of the workflow of the COCAT test procedure
concentration, run, and chemical were analyzed. Reproducibility of runs of an experiment (composed of three valid runs conducted on different days) was analyzed descriptively comparing solubility and cytotoxicity of tested concentrations, and lowest positive concentration for both ΔMFI (CD86 ≥ 10.8; CD54 ≥ 300).
In addition, concordance of classification of runs (non-sensitizer vs sensitizer) as obtained with the prediction model was calculated for the 15 test chemicals.
Results
Predictive capacity
Each test chemical was assessed in the COCAT in three individual runs. The concentration-dependent upregulation of CD86 and CD54, and the reduction of cell viability of THP-1 cells in each run are shown in Figure 1 for three exemplary chemicals. The predictive capacity of the COCAT in the blind study was assessed by comparing the in vitro predictions with LLNA and human reference results, from which identical skin sensitization potential/hazard was concluded for the 15 tested chemicals. As shown in Table 1 , the nine skin sensitizers were all correctly predicted in the COCAT, mainly driven by CD54. Also, three of the six non-sensitizers were correctly predicted. Salicylic acid was identified as a false positive in the COCAT, whereas no conclusion could be drawn for the two remaining non-sensitizers (hydrocortisone and propylparaben) due to limited solubility (incon-− Exclusion of overly dangerous test chemicals, such as explosive chemicals; − Exclusion of unstable chemicals, such as oxidizing and polymerizing agents; − Exclusion of overly hazardous test chemicals, such as carcinogens, reproductive toxicants, and mutagens. Acquisition, coding and distribution of chemicals was conducted independently by VITO (Belgium) using appropriate packaging. Information received by Trier University on the chemicals to be tested comprised the approximate molecular weight (MW), the physical form, and storage conditions. In addition, sealed envelopes containing health and safety information were dispatched to the Safety Officer appointed by Trier University (Dr Udo Bock). The sealed envelopes were sent back to SeCAM after the experimental study phase, where it was confirmed that no envelopes had been opened.
Data collection, handling, and analyses
The data collection spreadsheets used for reporting the study data were prepared by Trier University and reviewed by the biostatistician of the study. The raw data produced during the blind study by Trier University were provided to the study biostatistician, who collected, managed, and analyzed the data. After hazard prediction and unblinding of the coded test chemicals, the data were reanalyzed with the corrected MW.
Data processed according to the SOP to obtain mean cell viability, mean CD86 ΔMFI, and mean CD54 ΔMFI for each test The induction of CD86 and CD54 was well reproducible between runs for most chemicals when considering the lowest concentrations inducing these markers above the respective thresholds (Fig. 2 , Tab. S11). Regarding CD86, clear differences were observed for two chemicals (p-phenylenediamine and coumarin). The CD86 reproducibility of resorcinol was affected by the differences in cytotoxicity between the runs (the borderline cytotoxic concentration of 4540.9 µM induced CD86 above the threshold). Regarding CD54, there were clear differences between the runs for p-phenylenediamine and linalool, while the positive run for benzalkonium chloride was only borderline positive.
In summary, the reproducibility of runs when testing 15 coded chemicals was 80% or higher for cytotoxicity and for the two cell surface markers, regardless of the analysis (concentration and prediction).
Prediction of UN GHS sub-categories 1A and 1B
Beside hazard identification, the capacity of the COCAT to categorize chemicals according to their skin sensitizing potency was also assessed in this study. To enlarge the database for the assessment of the capacity of COCAT to discriminate UN GHS skin sensitization sub-categories 1A vs 1B, results of the blind study were combined with results obtained earlier (published in Goebel et al., 2014; Blömeke, 2017a,b, 2018; unpublished data) , yielding a total of 26 skin sensitizers and 13 non-sensitizers. These earlier results were obtained using a 6-well format protocol or a protocol with minor variations clusive). In summary, the COCAT correctly predicted 12 out of 13 (excluding hydrocortisone and propylparaben due to reduced solubility) test chemicals, i.e., 92% when compared to the LLNA reference data. When compared to the human data, the same predictive capacity was observed if human categories 1 to 4 are considered sensitizers and human categories 5 and 6 are considered non-sensitizers as described by Basketter et al. (2014) .
Reproducibility
Reproducibility between runs of an experiment (composed of at least three valid runs conducted on different days and containing triplicate measurements within each run) was analyzed descriptively by comparing cytotoxicity of test concentrations and lowest positive concentration for both ΔMFI (CD86 ≥ 10.8; CD54 ≥ 300, Tab. S1 1 ). In addition, concordance of classification of runs (non-sensitizer vs sensitizer) as obtained with the prediction model was calculated across the 15 test chemicals.
As shown in Table S1 1 , the cytotoxicity between runs was identical for 12 of the 15 test chemicals (i.e., 80%) when using the lowest concentration leading to a compound-induced reduction of cell viability of not more than 35% as determined by propidium iodide staining. Minor differences were observed for methyldibromo glutaronitrile (difference by a factor of 2, i.e., one dilution step) and p-phenylenediamine (difference by a factor of 4). Resorcinol gave a cell viability of 49.3% (just below the cut-off value of 50%) for the highest test concentration in the third run.
Fig. 2: Concentrationdependent up-regulation of CD86 (A, C, and E) and CD54 (B, D, and F) on viable THP-1 cells in the COCAT after 24 h chemical exposure
The individual runs for isoeugenol (A,B) , linalool (C,D), and resorcinol (E,F) as representative chemicals are shown. The dashed line represents the limit of viability accepted in the COCAT (i.e., reduction of viability to 50%), the blue and green horizontal lines represent the threshold for positivity for CD86 or CD54 with a ΔMFI of 10.8 or 300, respectively. (Hoffmann et al., 2018; Urbisch et al., 2015; Rudback et al., 2014; Johansson et al., 2008; Goebel et al., 2014) . a ECΔ published in Hennen and Blömeke (2017a) ; b ECΔ published in Hennen and Blömeke (2017b) ; c ECΔ published in Hennen and Blömeke (2018) ; d ECΔ published in Goebel et al. (2014) ; n.a., not available.
Tab. 2: Overview of the compiled results for hazard, UN GHS sub-categories and potency prediction
Discussion
The identification and characterization of a chemical's potential to induce skin sensitization is a prerequisite for its risk assessment. The Cosmetics Regulation 1223/2009 (EU, 2009) prohibits animal testing for individual ingredients and finished products, and also the European Union's REACH Regulation (EU, 2016) demands the use of alternative methods where applicable. Furthermore, estimation of potency is critical for risk assessment and the sub-categorization of skin sensitizers according to their potency into UN GHS subcategories 1A or 1B is mandatory under the REACH Regulation (EU, 2016).
The regulatory accepted methods (OECD 2018a,b, 2019) have been validated for the purpose of hazard identification. Several defined approaches integrating results obtained from individual methods, each representing one key event of the AOP for skin sensitization, have been evaluated for their capacity to predict potency. However, there is considerable uncertainty about the application of the various combinations of non-animal methods for the assessment of chemical skin sensitization potential and potency for regulatory decision-making, e.g., for the purposes of REACH or classification according to the CLP Regulation (ECHA, 2018; EU, 2006 EU, , 2008 EU, , 2016 .
In contrast to the regulatory accepted methods, the COCAT combines two cell types, i.e., HaCaT keratinocytes (included in OECD TG 442D addressing key event 2, activation of keratinocytes) and THP-1 cells (included in OECD TG 442E addressing key event 3, activation of dendritic cells) (Emter et al., 2010; Ramirez et al., 2014; Takahashi et al., 2011; Ashikaga et al., 2006) . These two cell types are directly cocultured in the COCAT, allowing for co-exposure and cross-talk between them. Such interaction has been found to have the potential to enhance the response of THP-1 cells to sensitizing agents, and to improve the detection of pro-haptens, thus improving the sensitivity of the assay (Hennen and Blömeke, 2017a) . Furthermore, the combination of dendritic cell activation with keratinocyte responses to skin sensitizing chemicals has been found to support the identification of skin sensitization potency Blömeke, 2017a, 2018; Goebel et al., 2014) . Following in the selection of test concentrations in some cases, which were found to not impact on the overall result. The summary of all results for the 39 chemicals is shown in Table 2 .
In order to assign sensitizers into UN GHS sub-categories 1A or 1B based on the lowest positive concentration in the CO-CAT (ECΔ), a cut-off of 300 µM was used ( Fig. 3 and Tab. 3). Using this cut-off to distinguish skin sensitizers with UN GHS sub-category 1A from 1B allowed to correctly predict 12 of 13 skin sensitizers of sub-category 1A and 11 of 13 skin sensitizers of sub-category 1B (comparing to sub-categorization based on LLNA EC3 values), representing a total of 23 of 26 correctly predicted sub-category 1A or 1B sensitizers (85.5%). In addition, 12 of the 13 non-sensitizers were correctly predicted as such (92.3%). One sub-category 1A sensitizer (out of 13) was under-predicted as sub-category 1B sensitizer. Furthermore, two sub-category 1B (out of 14) sensitizers were over-predicted as sub-category 1A and one non-sensitizer was over-predicted as sub-category 1B (salicylic acid). No skin sensitizer yielded a false-negative result. Altogether, an overall concordance of 87.4% (34/39) correct predictions of UN GHS sub-categories (1A, 1B and non-sensitizers) was found, underlining the high capacity of COCAT for predicting potency sub-categories according to the UN GHS classification scheme.
Fig. 3: Categorization of sensitizers into GHS sub-categories 1A or 1B according to ECΔ determined in the COCAT
Results for 26 sensitizers tested in the optimization phase (17 sensitizers, dark blue circle) or in the blind study (9 sensitizers, green circle and false positive tested chemical as red triangle) are shown. The calculated ECΔ are summarized in Table 3 . NC, no category
Tab. 3: Contingency table of LLNA versus COCAT predictions
Discriminating between sub-category 1A, sub-category 1B, and no category using the cut-off of 300 µM as the lowest concentration needed for positivity in COCAT (ECΔ) to trigger prediction of sub-category 1A. UN GHS sub-category 1A from 1B allowed to correctly predict 23 out of the 26 sensitizers (88.5%) and 12 of the 13 non-sensitizers (92.3%), achieving an overall concordance of 87.4% (34/39) for predicting the UN GHS sub-categories 1A, 1B and non-sensitizers. A detailed analysis of the data revealed that all but one chemical reached positivity for CD54 at a lower concentration than CD86. Consequently, potency prediction in COCAT was dominated by the chemicals' capacity to upregulate CD54. In line, the interaction of adhesion molecule CD54 and its counterpart (LFA-1) on T cells was found to not only mediate intercellular binding but also to deliver signals to T cells. Specifically, it was found to decrease the threshold of naïve T cell activation and antigen dose required for T cell activation (Wang et al., 2008) . This underlines the importance of the chemicals' potential to upregulate CD54 and its quantitative relationship with potency prediction, i.e., the amount of chemical required for the induction of skin sensitization. Nevertheless, CD54 is only addressed in h-CLAT and COCAT, while other assays such as U-SENS, the IL-8 Luc assay, or the GARD assay do not comprise the analysis of CD54 upregulation by chemicals (Wong et al., 2015; Ashikaga et al., 2006; Piroird et al., 2015; Takahashi et al., 2011; Johansson et al., 2013) . However, the concentration needed for a sufficient upregulation of CD54 on THP-1 cells was found to be modulated by adjacent HaCaT keratinocytes by a factor of up to 9 in COCAT, crucially impacting on its capacity to estimate the this proof-of-principle, the test protocol was optimized to allow an increased throughput of the COCAT by using 96-well plates and to define the COCAT's critical protocol steps such as cell viability assessment, the prediction model used, the concentration ranges to be tested, definition of positive and negative controls, and the definition of a strategy for test chemical solubilization. The optimized protocol 1 was then applied in this intra-laboratory pre-validation study. Results from the blind intra-laboratory phase of the present study, in which 15 coded chemicals were tested in three independent runs composed of triplicates within each run, showed the assay to be reproducible, achieving a reproducibility between runs of 80% (12 out of 15) or higher for cytotoxicity and for the two markers (CD86 and CD54), regardless of the analysis (concentration and prediction). Furthermore, it showed the correct prediction of 9 out of 9 skin sensitizers, and of 3 out of 4 non-sensitizers, resulting in an overall accuracy of 92.3% (12/13) for LLNA and human hazard reference data. Comparison of the results of the blind study with predictions from currently adopted in vitro assays using HaCaT or THP-1 cells alone (i.e., KeratinoSens™, h-CLAT) demonstrated a similar or better performance of the COCAT (Tab. 4).
COCAT
When combining the results obtained from the optimization and blind studies, a sensitivity of 100% (26/26), a specificity of 92.3% (12/13), and an overall accuracy of 97.4% (38/39) was achieved for the identification of skin sensitization hazards. Using 300 µM as cut-off for distinguishing skin sensitizers of Tab. 4: Comparison of COCAT hazard prediction with currently adopted monoculture assays that are individually used in two OECD test guidelines which address key events 2 (KeratinoSens TM ) and 3 (h-CLAT) of the skin sensitization AOP chemicals' sensitizing potency (Hennen and Blömeke, 2017a ).
In the present study, comparison of the ECΔ values obtained in COCAT with LLNA EC3 values led to a highly comparable assignment of chemicals into UN GHS potency sub-categories (Tab. 3), and the results also indicate a potential of COCAT for a more refined potency prediction on a continuous scale (Fig. 3) as, e.g., needed for the quantitative risk assessment of chemicals such as cosmetic ingredients.
Overall, the present study shows the COCAT method, integrating two key events of the AOP, not only to be a reproducible method that is promising for the identification of skin sensitization hazard, but also its capacity for sub-categorization according to the UN GHS classification sub-categorization scheme and possibly potency in a more detailed manner. Thus, the COCAT has the potential to provide data needed to fulfil the updated information requirements of REACH and also to support quantitative risk assessment using non-animal methods for other regulatory purposes.
